VD

Vasa Denticity Ltd

Q2 FY27Healthcare Equipment & Supplies

Vasa Denticity Q2 Results 2026 (FY27) statement: Revenue & Margins

Q2 FY27 results statement: what the company reported on revenue, margins and capex.

Revenue
₹86Cr
+18.3% YoY
Net profit
₹5Cr
+4.2% YoY
Margin
8.22%
−0.1 pp YoY

Vasa Denticity Ltd Q2 FY27 key numbers

Revenue
Revenue from Operations for the quarter ended September 30, 2026: Rs. 17,023.64 Lacs.

As stated in Vasa Denticity Ltd's Q2 FY27 results statement · published 7 Nov 2026. Reported figures, not investment advice.

Based on Vasa Denticity Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

Price₹447
Market cap₹775 Cr
P/E64.1

The short version

Revenue from Operations for the quarter ended September 30, 2026: Rs. 17,023.64 Lacs. Quarterly EBITDA: Rs. 639.10 Lacs for Q2 FY 2026 (vs.

From Vasa Denticity Ltd's Q2 FY27 earnings-call transcript · updated 7 Nov 2026.

How did Vasa Denticity's revenue grow in the September 2026 quarter?

- Revenue from Operations for the quarter ended September 30, 2026: Rs. 17,023.64 Lacs - Revenue from Operations for the quarter ended September 30, 2025: Rs. 8,709.77 Lacs - Year-on-year revenue growth: Approximately 95.3% increase in revenue from Rs. 8,709.77 Lacs to Rs. 17,023.64 Lacs - Other income for the quarter ended September 30, 2026: Rs. 145.21 Lacs All figures are based on the consolidated unaudited financial results as reported on page 9 of the presentation.

What happened to Vasa Denticity's margins in Q2 FY27?

See what Vasa Denticity Ltd said on profitability & margins — free account, 30 seconds.

What capex is Vasa Denticity planning?

See what Vasa Denticity Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
1OSEL Devices
Rev 1Mar 3
Rev 1Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Vasa Denticity raising money or cutting debt?

See what Vasa Denticity Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Vasa Denticity's order book?

See what Vasa Denticity Ltd said on order book & pipeline — free account, 30 seconds.

Vasa Denticity Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Vasa Denticity Ltd Q2 FY27 results — key figures

Vasa Denticity Ltd Q2 FY27 reported results vs Q2 FY26, ₹ crore
₹ CrQ2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue8673+18.3%82+4.7%
Operating profit (EBITDA)76+16.5%5+39.2%
Operating margin8.22%8.35%-0.1 pp6.18%+2 pp
Profit before tax76+8.8%5+30.9%
Net profit (PAT)55+4.2%4+24.1%
EPS (₹)2.972.88+3.1%2.40+23.8%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹86 Cr, net profit ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Equipment & Supplies this season

  • Vaidya Sane (Q2 FY27)

    Year-on-year (YoY) change: +23% (from INR 687 Lakhs in Sep 2025) . Key results statement takeaways from Vaidya Sane Ayurved Laboratories Ltd's Q2 FY27 results s

  • Sahajanand Medi (Q2 FY27)

    Slight seasonality in revenue with H2 being marginally higher (~52%) than H1 (~48%). Key concall takeaways from Sahajanand Medical Technologies Ltd's Q2 FY27…

  • Molbio Diagnosti (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹259.0 Cr vs ₹580.3 Cr in Q2 FY26 (significant decrease due to rate contract negotiations). Key investor presentation takeaways

  • Poly Medicure (Q2 FY27)

    Q2 FY27 consolidated revenue from operations: Rs 580.5 Cr, up 30.8% YoY (Q2 FY26: Rs 443.9 Cr). Key investor presentation takeaways from Poly Medicure Ltd's Q2

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Vasa Denticity Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Vasa Denticity Ltd Q2 FY27 results?

Revenue from Operations for the quarter ended September 30, 2026: Rs. 17,023.64 Lacs. Quarterly EBITDA: Rs. 639.10 Lacs for Q2 FY 2026 (vs.

What is Vasa Denticity Ltd share price analysis?

Vasa Denticity Ltd currently shows a neutral. The stock trades at a P/E of 64.1 with a market cap of ₹775 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Vasa Denticity Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.